Editorial draft · writing/deep-dive-plants-gods-peyote-crisis

Peyote Under Pressure: Conservation, Native Rights, and the Psychedelic Industry

Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.

Deep DivePlants of the Gods661 words4 source entriesstatus: editorial complete

Peyote Under Pressure: Conservation, Native Rights, and the Psychedelic Industry

“Peyote is not a recreational drug that happens to be used ceremonially. It …”
policyethnobotany
“Peyote is not a recreational drug that happens to be used ceremonially. It is a sacrament under ecological pressure from the same forces that benefit financially from other psychedelics becoming legal. This is the most acute ethical contradiction in the current psychedelic moment.”

Richard Evans Schultes documented peyote ceremonies with the Huichol (Wixáritari) people of central Mexico in the 1930s and 1940s, the weeks-long pilgrimage to Wirikuta, the sacred desert where peyote grows; the careful harvesting protocol that leaves the root system intact; the prayers that accompany each cut. He was observing a practice continuous for at least 5,000 years, possibly much longer. Peyote use is documented in the archaeological record of northeastern Mexico at least from 3780-3660 BCE.

As of 2026, Lophophora williamsii, peyote, is listed as vulnerable on the IUCN Red List. Its range in Texas and northern Mexico has contracted by more than 30% since the 1970s due to habitat loss, agricultural expansion, ranching, and overharvesting. The conservation crisis Schultes warned about has materialized.

The NAC DIMENSION

Approximately 250,000-500,000 members of the Native American Church use peyote ceremonially in the United States. The legal protection for this use, established by the 1994 AIRFA amendments after the Supreme Court's 1990 Employment Division v. Smith decision removed constitutional protection, is specific to Native American Church members and bona fide ceremonial use. Non-Native ceremonial use of peyote is not federally protected.

The NAC does not buy peyote from commercial distributors. It sources it from licensed distributors in Texas, the only US state where peyote grows commercially, who harvest from private ranchlands under DEA license. The supply is constrained by the limited range, the slow growth rate of the plant (it takes 10-20 years to reach harvestable size), and the increasing demand from a growing NAC membership base.

The NAC has explicitly requested that peyote be excluded from psychedelic decriminalization and legalization measures. Colorado's Proposition 122 honored this request, it decriminalized mescaline while specifically excluding peyote. Oregon's Measure 109 does not address peyote. The NAC's concern is straightforward: any expansion of legal access to peyote beyond current NAC ceremonial use will increase harvesting pressure on a plant already under conservation threat, and will appropriate a sacred practice without the cultural context that gives it meaning.

THE INDUSTRY CONTRADICTION

The psychedelic industry's relationship to peyote is the most acute ethical contradiction in the current moment. Mescaline, the active compound in peyote, is of commercial interest as a therapeutic compound. Several companies have filed patents for mescaline derivatives and synthetic mescaline production processes. Synthetic mescaline, produced in a laboratory, would not require peyote harvesting and would not raise conservation concerns. The NAC has not objected to synthetic mescaline research.

The objection is to the cultural context: the use of peyote or its derivatives in therapeutic or recreational frameworks that extract the pharmacological compound from the ceremonial tradition that developed it, stewarded it, and protected it through a century of criminalization. From the NAC's perspective, the psychedelic industry's interest in mescaline-derived compounds is another form of the extraction that has characterized Indigenous-Western relations for five centuries, taking the useful part without acknowledging the source.

Schultes's documentation of the Huichol peyote pilgrimage in Plants of the Gods was careful and respectful. He understood that the ceremony was inseparable from the plant's meaning. The current psychedelic industry's engagement with mescaline and peyote derivatives is largely divorced from that understanding, focused on the pharmacological mechanism, not the cultural context.

THE CONSERVATION PATH

Several conservation projects are attempting to address the peyote shortage. The Multidisciplinary Association for Psychedelic Studies (MAPS) has supported peyote cultivation research. The Cactus Conservation Institute documents peyote populations. Some NAC members and affiliated organizations have established small-scale cultivation operations. The growth rate of the plant, the same characteristic that Schultes documented in Huichol harvesting protocols, makes scaling cultivation difficult. A peyote cactus planted today will not be harvestable for a decade.

The conservation problem and the cultural appropriation problem are connected: the resolution that serves both is synthetic mescaline for non-Native therapeutic use, combined with legal protection for NAC ceremonial use of natural peyote, combined with funded conservation of wild peyote populations. This framework has been articulated by the NAC and has not been implemented at policy level.

Sources

  • Schultes & Hofmann, Plants of the Gods (1979)
  • Labate & Cavnar, Peyote: History, Tradition, Politics, and Conservation (2016)
  • Gehr, Drugs of the Dreamtime (2021) [Source not found; under review]
  • Native American Church of North America, Conservation Statement (2023)